Mytos Announces $19M Series A Funding to Automate Human Cell Manufacturing and Further Accelerate Growth
Newsroom
Mytos Announces Manufacturing Collaboration with Aspen Neuroscience in Parkinson’s Disease
January 8th, 2025
Mytos’ iDEM technology will power manufacturing of neuronal precursor cells for Aspen’s ANPD001 investigational cell therapy for Parkinson’s disease.
Pushing The Frontiers of Human Cell Manufacturing — Mytos Announces $19M Series A
This Startup Just Raised $19 Million To Bring An Industrial Revolution To Biology
Cell manufacturing company raises $19M Series A to increase capacity, staff numbers
Mytos Announces $19M Series A Funding to Automate Human Cell Manufacturing and Further Accelerate Growth